Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors

Area of Science:

• Biomaterials Science
• Gene Therapy
• Nanotechnology

Background:

• Gene therapy requires efficient and safe delivery vectors for nucleic acids.
• Current vectors like Lipofectamine 2000 and branched polyethylenimine (bPEI) have limitations in efficiency and/or toxicity.
• Novel nanocarriers are needed to improve gene delivery systems.

Purpose of the Study:

• To synthesize and characterize a novel family of branched polyrotaxanes (bPRTx(+)) for gene silencing applications.
• To evaluate the complexation ability, size, and charge of bPRTx(+) with siRNA.
• To assess the gene-silencing efficiency and toxicity of bPRTx(+) compared to established vectors.

Main Methods:

• Synthesis of branched polyrotaxanes (bPRTx(+)) using a multi-armed poly(ethylene glycol) (PEG) core and cationic α-cyclodextrins (α-CDs).
• Complexation studies with small interfering RNA (siRNA) to form nanoparticles.
• Characterization of nanoparticle size and surface charge (zeta potential).
• In vitro evaluation of gene-silencing efficiency and cytotoxicity assays.

Main Results:

• Stable, positively charged nanoparticles (150-250 nm) were formed at low N/P ratios (as low as 2.5).
• bPRTx(+) demonstrated gene-silencing efficiencies comparable to Lipofectamine 2000 (L2k) and bPEI.
• Toxicity profiles of bPRTx(+) were similar to L2k and bPEI.
• Effective condensation of siRNA into nanoparticles at significantly lower N/P ratios than L2k or bPEI.

Conclusions:

• Branched polyrotaxanes (bPRTx(+)) are effective siRNA delivery vectors.
• These novel materials offer comparable gene-silencing performance and toxicity to existing standards.
• The unique polyrotaxane structure facilitates efficient complexation at low N/P ratios, highlighting their potential for gene therapy.